Somapacitan Recruiting Phase 3 Trials for SGA, Turner Syndrome, Noonan Syndrome, ISS Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05330325A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow